Skip to main content
SpringerLink
Log in

Some complementary therapies have possible effects on the motor symptoms of Parkinson’s disease

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Zesiewicz TA, Evatt ML. Potential influences of complementary therapy on motor and non-motor complications in Parkinson’s disease. CNS Drugs 2009; 23(10): 817–35

    Article  PubMed  CAS  Google Scholar 

  2. Wolfrath SC, Borenstein AR, Schwartz S, et al. Use of nutritional supplements in Parkinson’s disease patients. Mov Disord 2006 Aug; 21(8): 1098–101

    Article  PubMed  Google Scholar 

  3. Suchowersky O, Gronseth G, Perlmutter J, et al. Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006 Apr 11; 66(7): 976–82

    Article  PubMed  CAS  Google Scholar 

  4. Astarloa R, Mena MA, Sánchez V, et al. Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. Clin Neuropharmacol 1992 Oct; 15(5): 375–80

    Article  PubMed  CAS  Google Scholar 

  5. Barichella M, Marczewska A, De Notaris R, et al. Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson’s disease. Mov Disord 2006 Oct; 21(10): 1682–7

    Article  PubMed  Google Scholar 

  6. Wolfe RR, Miller SL, Miller KB. Optimal protein intake in the elderly. Clin Nutr 2008 Oct; 27(5): 675–84

    Article  PubMed  CAS  Google Scholar 

  7. Barichella M, Savardi C, Mauri A, et al. Diet with LPP for renal patients increases daily energy expenditure and improves motor function in parkinsonian patients with motor fluctuations. Nutr Neurosci 2007 Jun–Aug; 10(3–4): 129–35

    Article  PubMed  CAS  Google Scholar 

  8. Vanitallie TB, Nonas C, Di Rocco A, et al. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 2005 Feb 22; 64(4): 728–30

    Article  PubMed  CAS  Google Scholar 

  9. de Lau LM, Bornebroek M, Witteman JC, et al. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology 2005 Jun 28; 64(12): 2040–5

    Article  PubMed  Google Scholar 

  10. Gao X, Chen H, Choi HK, et al. Diet, urate, and Parkinson’s disease risk in men. Am J Epidemiol 2008 Apr 1; 167(7): 831–8

    Article  PubMed  Google Scholar 

  11. Chen H, O’Reilly E, McCullough ML, et al. Consumption of dairy products and risk of Parkinson’s disease. Am J Epidemiol 2007 May 1; 165(9): 998–1006

    Article  PubMed  Google Scholar 

  12. Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 2007 Nov; 86(5): 1486–94

    PubMed  CAS  Google Scholar 

  13. Bender A, Koch W, Elstner M, et al. Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology 2006 Oct 10; 67(7): 1262–4

    Article  PubMed  CAS  Google Scholar 

  14. The NINDS NET-PD Investigators. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin Neuropharmacol 2008 May–Jun; 31(3): 141–50

    Article  Google Scholar 

  15. Hass CJ, Collins MA, Juncos JL. Resistance training with creatine monohydrate improves upper-body strength in patients with Parkinson disease: a randomized trial. Neurorehabil Neural Repair 2007 Mar–Apr; 21(2): 107–15

    Article  PubMed  Google Scholar 

  16. Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson’s disease: a meta-analysis. Lancet Neurol 2005 Jun; 4(6): 362–5

    Article  PubMed  CAS  Google Scholar 

  17. Newmark HL, Newmark J. Vitamin D and Parkinson’s disease: a hypothesis. Mov Disord 2007 Mar 15; 22(4): 461–8

    Article  PubMed  Google Scholar 

  18. Chen H, Zhang SM, Schwarzschild MA, et al. Folate intake and risk of Parkinson’s disease. Am J Epidemiol 2004 Aug 15; 160(4): 368–75

    Article  PubMed  Google Scholar 

  19. de Lau LM, Koudstaal PJ, Witteman JC, et al. Dietary folate, vitamin B12, and vitamin B6and the risk of Parkinson disease. Neurology 2006 Jul 25; 67(2): 315–8

    Article  PubMed  Google Scholar 

  20. Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002 Oct; 59(10): 1541–50

    Article  PubMed  Google Scholar 

  21. The NINDS NET-PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology 2007 Jan 2; 68(1): 20–8

    Article  Google Scholar 

  22. Storch A, Jost WH, Vieregge P, et al. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q (10) in Parkinson disease. Arch Neurol 2007 Jul; 64(7): 938–44

    Article  PubMed  Google Scholar 

  23. Campbell RR, Hasinoff B, Chernenko G, et al. The effect of ferrous sulfate and pH on L-dopa absorption. Can J Physiol Pharmacol 1990 May; 68(5): 603–7

    Article  PubMed  CAS  Google Scholar 

  24. Chung V, Liu L, Bian Z, et al. Efficacy and safety of herbal medicines for idiopathic Parkinson’s disease: a systematic review. Mov Disord 2006 Oct; 21(10): 1709–15

    Article  PubMed  Google Scholar 

  25. Katzenschlager R, Evans A, Manson A, et al. Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry 2004 Dec; 75(12): 1672–7

    Article  PubMed  CAS  Google Scholar 

  26. Sharma H, Chandola HM, Singh G, et al. Utilization of Ayurveda in health care: an approach for prevention, health promotion, and treatment of disease: II. Ayurveda in primary health care. J Altern Complement Med 2007 Dec; 13(10): 1135–50

    Article  PubMed  Google Scholar 

  27. Dhanasekaran M, Tharakan B, Manyam BV. Antiparkinson drug: Mucuna pruriens shows antioxidant and metal chelating activity. Phytother Res 2008 Jan; 22(1): 6–11

    Article  PubMed  CAS  Google Scholar 

  28. Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, et al. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease: a randomized, double blind, placebo-controlled study. J Neurol 2007 Apr; 254(4): 459–64

    Article  PubMed  CAS  Google Scholar 

  29. Dowling GA, Mastick J, Colling E, et al. Melatonin for sleep disturbances in Parkinson’s disease. Sleep Med 2005 Sep; 6(5): 459–66

    Article  PubMed  Google Scholar 

  30. Villafane G, Cesaro P, Rialland A, et al. Chronic high dose transdermal nicotine in Parkinson’s disease: an open trial. Eur J Neurol 2007 Dec; 14(12): 1313–6

    Article  PubMed  CAS  Google Scholar 

  31. Simon DK, Swearingen CJ, Hauser RA, et al. Caffeine and progression of Parkinson disease. Clin Neuropharmacol 2008 Jul–Aug; 31(4): 189–96

    Article  PubMed  CAS  Google Scholar 

  32. Kandinov B, Giladi N, Korczyn AD. The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson’s disease. Parkinsonism Relat Disord 2007 May; 13(4): 243–5

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Some complementary therapies have possible effects on the motor symptoms of Parkinson’s disease. Drugs Ther. Perspect 26, 10–13 (2010). https://doi.org/10.2165/11205260-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11205260-000000000-00000

Search

Navigation